Open AccessAvibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients
Author(s) -
Hussein Chalhoub,
Michael M. Tunney,
J.S. Elborn,
Anne Vergison,
Olivier Denis,
Patrick Plésiat,
Barbara C. Kahl,
Françoise Van Bambeke,
Paul M. Tulkens
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku551
Subject(s) - ceftazidime/avibactam , pseudomonas aeruginosa , cystic fibrosis , ceftazidime , microbiology and biotechnology , avibactam , pseudomonadaceae , medicine , biology , bacteria , genetics
info:eu-repo/semantics/publishe
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom